Skip to main content
Livermore
Livermore
ZHEN

Private Advisor Group, LLC

SEC CIK
0001567755
Latest filing
Jul 27, 2026

CTMX holding history

CytomX Therapeutics, Inc. in every 13F filed by Private Advisor Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CTMX overviewAll 13F holders of CTMXFull Q2 2026 holdings

Shares (Q2 2026)
54,502
Value
$204.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CTMX by Private Advisor Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202654,502$204.4K<0.1%+10,500+23.9%AddedHolders
Q1 202644,002$206.8K<0.1%00.0%UnchangedHolders
Q4 202544,002$187.4K<0.1%00.0%UnchangedHolders
Q3 202544,002$140.4K<0.1%00.0%UnchangedHolders
Q2 202544,002$99.9K<0.1%00.0%UnchangedHolders
Q1 202544,002$28.0K<0.1%00.0%UnchangedHolders
Q4 202444,002$45.3K<0.1%−8,177−15.7%ReducedHolders
Q3 202452,179$61.6K<0.1%00.0%UnchangedHolders
Q2 202452,179$63.7K<0.1%−17,000−24.6%ReducedHolders
Q1 202469,179$150.8K<0.1%−4,000−5.5%ReducedHolders
Q4 202373,179$113.4K<0.1%00.0%UnchangedHolders
Q3 202373,179$94.4K<0.1%00.0%UnchangedHolders
Q2 202373,179$126.5K<0.1%00.0%UnchangedHolders
Q1 202373,179$110.5K<0.1%−10,000−12.0%ReducedHolders
Q4 202283,179$62.8K<0.1%00.0%UnchangedHolders
Q3 202283,179$121.0K<0.1%−1,000−1.2%ReducedHolders
Q2 202284,179$155.0K<0.1%00.0%UnchangedHolders
Q1 202284,179$224.0K<0.1%00.0%UnchangedHolders
Q4 202184,179$365.0K<0.1%−40,177−32.3%ReducedHolders
Q3 2021124,356$634.0K<0.1%+40,177+47.7%AddedHolders
Q2 202184,179$533.0K<0.1%−1,000−1.2%ReducedHolders
Q1 202185,179$658.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.